50k per does does not seem correct. At one point when the solid tumor trials were in progress they had 250+ patients being treated. At 50k per treatment that would be 25 million for each 28 day cycle and thus at least 75 million per quarter. I believe Geron's entire cash burn rate per quarter peaked around 18 million per quarter.
Sounds like a customized treatment. Not many details about how the treatment is created or how broadly applicable it is. Seems promising. If you have more details I would like to see.
Are you serious? LOL get out the ouija board tell me and tell me when we have a head and shoulders with dandruf
This is completely inaccurate. 163 existed long before GRN1005. There was talk of combining the 2 but it never happened. GRN1005 never had anything to do with telomerase
about the only words he uses are ... booyah BUY BUY BUY or SELL SELL SELL
That's what you say when someone asks you for a recommendation on a stock you know nothing about.
You don't understand Lincoln Capital. The don't "Invest". They get the shares at a slight discount and dump for a profit as soon as they can. They did this with ACTC, STEM and many others. It suppresses the PPS for the entire time it is happening. They probably don't any other choice but it's not pretty... and I am long a small position so I'm not trying to bash.
My guess would be that until they finalize plans they won't know the cost of the trial and how much capital to raise. Number of patients, number of sites , duration....
There is definitely going to be pressure until Friday.
She sure did. She said her husband was the PR in the results and in 1 month he will likely be considered a CR. So in all likelyhood the longer the patients stay on Imetelstat the higher the response rate. This is significant.
" I don't know much about trading (child psychologist PHD)"
Irishtrader. If you are a child psychologist then you understand the vast majority of traders. Reactionary and shortsighted.
It is funny how all of the new pumping aliases showed up but Charlston Heston's last gig was being a shill for the NRA. It was pathetic. He looked to be completely senile at the time but a handler should have known better.
Joanie, his 200k shares is chump change. He had millions in stock option due to him as part of his employment contract. Even if Geron is bought out before the are exercisable he gets them all at once. He came on at 2.30 a share so he is looking good already
because he is a motley fool
You must be a biotechnovice. The "insiders" are sitting on millions of options and don't need to buy shares on the open market. I've been there. In Geron's case the high level long time insiders have all been shown the door and although no longer insiders they may very well still be holding their shares.
The purpose of Motley Fool is to get web hits and generate ad revenue. Any time a stock is in the spot light they will produce an article regardless of useful content.
When news hits they probably tell the dude looking at his fantasy sports to come up with an article pronto!